glp 1 and liver disease The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD GLP-1 receptor agonists may protect

Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands

For adults over 51, the AI is 21 grams daily for women and 30 grams daily for men

Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy)

doi:10.2337/dci22-0034 Rubino F, et al

Drug and Nutrition Interactions: Not Just Food for Thought

Ipamorelin amplifies that drive